![Michael Friedman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Friedman
Directeur/Membre du Conseil chez
GALERA THERAPEUTICS, INC.
Fortune : 3 665 $ au 30/06/2026
Profil
Mr. Michael Friedman is a Principal at EMERALD BIOVENTURES LLC.
He is on the Board of Directors at Galera Therapeutics, Inc. Mr. Friedman was previously employed as an Independent Director by Peak Bio, Inc. and a Senior Vice President by Ladenburg Thalmann & Co., Inc. He also served on the board at Akari Therapeutics Plc and Platform Equity LLC.
He received his undergraduate degree from the University of Wisconsin and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 41 645 ( 0,02 % ) | 3 665 $ | 30/06/2026 |
Postes actifs de Michael Friedman
| Sociétés | Poste | Début |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/12/2024 |
Anciens postes connus de Michael Friedman
| Sociétés | Poste | Fin |
|---|---|---|
| PEAK BIO, INC. | Directeur/Membre du Conseil | 19/07/2024 |
Ladenburg Thalmann & Co., Inc.
 Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | 01/01/2023 |
Platform Equity LLC
 Platform Equity LLC Investment ManagersFinance Platform Equity seeks investment opportunities in companies located US. The Firm targets companies operating in the fields of entertainment and Digital media sector and provide financing for seed,early and later stage capital requirements. | Private Equity Investor | 01/06/2008 |
| AKARI THERAPEUTICS, PLC | Directeur-Opérations de Back Office | - |
Formation de Michael Friedman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Platform Equity LLC
Platform Equity LLC Investment ManagersFinance Platform Equity seeks investment opportunities in companies located US. The Firm targets companies operating in the fields of entertainment and Digital media sector and provide financing for seed,early and later stage capital requirements. | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
